论文部分内容阅读
为进一步探讨血清脂蛋白（ａ）［ＬＰ（ａ）］与脑血管病的关系，对１１８例脑血管病患者进行ＬＰ（ａ）检测，并与正常对照组比较。结果，脑血管病组ＬＰ（ａ）平均为４６８．７７±１４７．８４ｍｇ／Ｌ，显著高于正常对照组１２６．４２±８２．６１ｍｇ／Ｌ（Ｐ＜０．０１）；其中，脑出血、蛛网膜下腔出血及脑梗塞患者ＬＰ（ａ）平均水平亦显著高于正常对照组（Ｐ＜０．０１）；而ＬＰ（ａ）异常在脑血管病不同年龄及病程组间，差异无显著性（Ｐ＞０．０５）。分析表明，ＬＰ（ａ）升高与脑血管病发病显著相关，是脑血管病发病的重要危险因素。
To further explore the relationship between serum lipoprotein (a) [LP (a)] and cerebrovascular disease, 118 patients with cerebrovascular disease were tested for LP (a) and compared with the normal control group. Results The average LP (a) in patients with cerebrovascular disease was 468.77 ± 147.84mg / L, which was significantly higher than that of the normal control group (126.42 ± 82.61mg / L, P <0.01) The average level of LP (a) in patients with subarachnoid hemorrhage and cerebral infarction was also significantly higher than that in the normal control group (P <0.01). However, there was no significant difference in LP (a) between the different ages and course of cerebrovascular disease (P> 0.05). Analysis shows that, LP (a) increased and cerebrovascular disease was significantly related to the incidence of cerebrovascular disease is an important risk factor.